Agreed, however we do need capital. Hopefully we can do a tissue licensing deal in the interim to get us into initial human TAVR trials next year. It’s getting to the pointy end of things now. Irrespective of what happens the value on offer here is immense. IMO and DYOR.
- Forums
- ASX - By Stock
- Ann: DurAVR valve patient outcomes exceed expectations
Agreed, however we do need capital. Hopefully we can do a tissue...
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$13.19 |
Change
-0.010(0.08%) |
Mkt cap ! $279.0M |
Open | High | Low | Value | Volume |
$13.23 | $13.23 | $13.02 | $46.38K | 3.549K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 434 | $13.05 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.19 | 325 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 434 | 13.050 |
1 | 130 | 13.030 |
2 | 483 | 13.020 |
2 | 6 | 13.010 |
2 | 8 | 13.000 |
Price($) | Vol. | No. |
---|---|---|
13.190 | 325 | 1 |
13.200 | 1000 | 1 |
13.230 | 120 | 1 |
13.350 | 300 | 1 |
13.500 | 3567 | 3 |
Last trade - 10.35am 02/09/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online